Home BenefitsCell and gene therapy costs rising slowly but could reshape employer health plans: Research

Cell and gene therapy costs rising slowly but could reshape employer health plans: Research

by HR News Canada Staff
A+A-
Reset

A new study out of the United States finds that while cell and gene therapies remain rare in employer health plans, their…

Member Access Required

This article is available to registered HR News Canada members. Membership is free and provides full access to our independent reporting on workplace HR issues across Canada.

Join Free - Sign Up Now

Already a member? Log in below

Related Posts